Influenza Program, Thailand MOPH-US CDC Collaboration, Nonthaburi, Thailand.
Nakhon Phanom Provincial Hospital, Nakhon Phanom, Thailand.
PLoS One. 2023 Feb 3;18(2):e0279962. doi: 10.1371/journal.pone.0279962. eCollection 2023.
We measured the immunogenicity of seasonal trivalent inactivated influenza vaccines (IIV3) among older Thai adults and the effect of one-year prior vaccination status on immune responses.
Adults aged ≥65 years (n = 370) were vaccinated with Southern Hemisphere IIV3 in 2015. Hemagglutination inhibition assays were performed using goose red blood cells on sera collected from the participants at baseline and after 1, 6, and 12 months of vaccination. Prior year vaccination (in 2014) was verified with the national health security office database. We analyzed the associations between prior vaccination and geometric mean titers (GMT) at each time point using generalized linear regression on logged transformed titers, and seroprotection and seroconversion using Log-binomial regression.
At baseline, previously vaccinated participants (n = 203) had a significantly higher GMT and seroprotection against all three influenza strains than those previously unvaccinated (n = 167) (all p-values <0.001). Seroprotection rates were similar after one month in both groups for A(H1N1)pdm09 (adjusted risk ratio [aRR] 1.10, 95% CI 0.97-1.25), and A(H3N2) (aRR 1.08, 95% CI 0.87-1.33), but higher in previously vaccinated persons for B (aRR 1.20, 95% CI 1.08-1.32). At 12 months, 50% or more had seroprotection in previously vaccinated group with no difference between previously vaccinated or unvaccinated persons. Seroconversion was lower in the previously vaccinated group for A(H1N1)pdm09 (aRR 0.62, 95% CI 0.43-0.89), but did not differ between the two groups for A(H3N2) (aRR 0.94, 95% CI 0.69-1.28) and B (aRR 0.85, 95% CI 0.60-1.20).
Influenza vaccination elicited good humoral response in older Thai adults. While seroconversion seemed attenuated in persons previously vaccinated for influenza A(H1N1)pdm09 (the only vaccine strain not to change), this was not apparent for influenza A(H3N2) and B, and prior vaccination was not associated with any inhibition in seroprotection.
我们测量了季节性三价灭活流感疫苗(IIV3)在泰国老年人群中的免疫原性,以及前一年接种状态对免疫反应的影响。
370 名年龄≥65 岁的成年人在 2015 年接种了南半球 IIV3。在接种后 1、6 和 12 个月时,使用鹅红细胞在参与者的血清中进行血凝抑制试验。前一年(2014 年)的接种情况通过国家健康保障办公室数据库进行验证。我们使用对数转换后的滴度进行广义线性回归,分析了各时间点上先前接种与几何平均滴度(GMT)之间的关系,并使用对数二项式回归分析了血清保护和血清转化率。
在基线时,与之前未接种的参与者(n=167)相比,之前接种过疫苗的参与者(n=203)对所有三种流感株的 GMT 和血清保护率均显著更高(均 p 值<0.001)。两组中 A(H1N1)pdm09(调整风险比[aRR]1.10,95%置信区间[CI]0.97-1.25)和 A(H3N2)(aRR1.08,95%CI0.87-1.33)的一个月时血清保护率相似,但 B 型的血清保护率在之前接种过疫苗的人群中更高(aRR1.20,95%CI1.08-1.32)。12 个月时,之前接种过疫苗的人群中有 50%或更多的人具有血清保护作用,而之前接种过疫苗和未接种过疫苗的人群之间没有差异。A(H1N1)pdm09 的血清转化率在之前接种过疫苗的人群中较低(aRR0.62,95%CI0.43-0.89),但在 A(H3N2)(aRR0.94,95%CI0.69-1.28)和 B 型(aRR0.85,95%CI0.60-1.20)两组之间没有差异。
流感疫苗在泰国老年人群中引起了良好的体液免疫反应。虽然 A(H1N1)pdm09(唯一未改变的疫苗株)的既往接种者的血清转化率似乎降低,但在 A(H3N2)和 B 型中并不明显,而且既往接种与任何血清保护抑制均无关。